SCHEMBL6310290

SCHEMBL6310290

COC(=O)c1csc(N=C=O)n1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.43
ACHE P22303 1/20 0.43
MEN1 O00255 3/20 0.39
MAPT P10636 3/20 0.39
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 5/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
CRBN Q96SW2 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
GAA P10253 1/20 0.34
MAPK1 P28482 2/20 0.33
HRH3 Q9Y5N1 2/20 0.33
LMNA P02545 1/20 0.33
ATP4A P20648 1/20 0.33
ATP4B P51164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6313027 0.83 RAB9A (0.56) MAOAMEN1MAPTKMT2AALDH1A1
SCHEMBL6310434 0.81 KDM1A (0.40) MAPTALDH1A1NPC1RAB9A
SCHEMBL14656020 0.73 ACHE (0.64) MAOAACHEMEN1MAPTKMT2A
SCHEMBL6319096 0.73 ATP4A (0.33) MAPTALDH1A1NPC1RAB9AATP4A
SCHEMBL6981781 0.72 SMN1; SMN2 (0.47) MAOAACHEMEN1MAPTKMT2A
SCHEMBL6319437 0.72 KMT2A (0.44) MEN1MAPTKMT2AALDH1A1NPC1
SCHEMBL595766 0.72 MAOA (0.50) MAOAACHEMEN1MAPTKMT2A
SCHEMBL496467 0.72 MAOA (0.50) MAOAACHEMEN1MAPTKMT2A
SCHEMBL162485 0.72 MAOA (0.50) MAOAACHEMEN1MAPTKMT2A
SCHEMBL3333769 0.71 MAOA (0.47) MAOAACHEMEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143581-A1 Process for preparation of alkoxybenzamides and thiazolyl isocyanates MITSUI CHEMICALS, INC. (JP) 2005-06-30 US disclosed
EP-1489073-A1 PROCESS FORPREPARATION OF ALKOXYBENZAMIDES AND THIAZOLYL ISOCYANATES MITSUI CHEMICALS, INC. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143581-A1 Process for preparation of alkoxybenzamides and thiazolyl isocyanates CBR3, CBR1, IDH1 MAOA 2578/4885ACHE 1741/4885MEN1 4369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.